Rapid antimicrobial susceptibility testing for gram-negative blood infections shows no improvement in clinical outcomes ...
A randomized trial involving gram-negative bacterial bloodstream infections found that rapid antibiotic susceptibility ...
Abstract: The magnetic fields induced by the bias currents and the return currents flowing on a ground plane have a great influence on the performance of complex rapid single flux quantum (RSFQ) ...
Some fish in the Bahamas are experiencing a different kind of spring break—whether they want to or not. Sharks in the waters surrounding a remote area of the tropical island have tested positive for ...
I recently expressed my disagreement to a petition filed before the Supreme Court to issue a TRO on the successful and highly beneficial DOTr-NNIC partnership for the rehabilitation and further ...
Bird poop scraped off a man’s car appeared on a drug test as cocaine. A toddler’s ashes registered as methamphetamine or ecstasy. And a great-grandmother’s medicine tested positive for cocaine – ...
President Donald Trump's renewed aggressive posturing toward Iran has pushed bitcoin lower by roughly 2% over the past 24 hours to $67,000. While this price action is consistent with routine ...
Worldwide, billions of people rely on water sources whose hygienic quality is unclear or difficult to monitor. Conventional microbiological analysis methods take up to 24 hours, are costly, and ...
MANNER OF HER DEATH. THREE CHILDREN IN ARNOLD WERE FOUND WITH COCAINE IN THEIR SYSTEM. NOW, POLICE HAVE A SUSPECT. POLICE ARE TELLING US 30 YEAR OLD JOSIAH HUGHES LEFT THE ONE, THREE AND FIVE YEAR ...
Sharks in the Bahamas, including the Caribbean reef sharks, are ingesting drugs, a new study suggests. Reinhard Dirscherl / ullstein bild via Getty Images Sharks in the Bahamas are ingesting ...
Patients with urinary tract infections (UTIs) could receive the right antibiotic far sooner, thanks to a new test that produces results within hours rather than days. Researchers at the University of ...
HAMPTON, N.J., March 27, 2026 (GLOBE NEWSWIRE)-- Celldex (NASDAQ:CLDX) presented additional positive data from the completed Phase 2 clinical trials of barzolvolimab in chronic spontaneous urticaria ...